NO324220B1 - Fremgangsmate for fremstilling av en polymorf - Google Patents

Fremgangsmate for fremstilling av en polymorf

Info

Publication number
NO324220B1
NO324220B1 NO20030416A NO20030416A NO324220B1 NO 324220 B1 NO324220 B1 NO 324220B1 NO 20030416 A NO20030416 A NO 20030416A NO 20030416 A NO20030416 A NO 20030416A NO 324220 B1 NO324220 B1 NO 324220B1
Authority
NO
Norway
Prior art keywords
polymorph
preparing
Prior art date
Application number
NO20030416A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030416L (no
NO20030416D0 (no
Inventor
Laurence James Harris
Richard Anthony Storey
Albert Shaw Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20030416D0 publication Critical patent/NO20030416D0/no
Publication of NO20030416L publication Critical patent/NO20030416L/no
Publication of NO324220B1 publication Critical patent/NO324220B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20030416A 2000-07-28 2003-01-27 Fremgangsmate for fremstilling av en polymorf NO324220B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent
PCT/IB2001/001280 WO2002010171A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent

Publications (3)

Publication Number Publication Date
NO20030416D0 NO20030416D0 (no) 2003-01-27
NO20030416L NO20030416L (no) 2003-02-05
NO324220B1 true NO324220B1 (no) 2007-09-10

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030416A NO324220B1 (no) 2000-07-28 2003-01-27 Fremgangsmate for fremstilling av en polymorf

Country Status (46)

Country Link
EP (1) EP1305314B1 (xx)
JP (1) JP2004505087A (xx)
KR (1) KR100457937B1 (xx)
CN (1) CN1207297C (xx)
AP (1) AP1400A (xx)
AR (1) AR032628A1 (xx)
AT (1) ATE286901T1 (xx)
AU (2) AU7269001A (xx)
BG (1) BG107266A (xx)
BR (1) BR0112734A (xx)
CA (1) CA2417264C (xx)
CZ (1) CZ2003126A3 (xx)
DE (1) DE60108398T2 (xx)
DO (1) DOP2001000217A (xx)
DZ (1) DZ3364A1 (xx)
EA (1) EA004681B1 (xx)
EC (1) ECSP034454A (xx)
EE (1) EE200300045A (xx)
ES (1) ES2231521T3 (xx)
GE (1) GEP20053494B (xx)
HK (1) HK1055954A1 (xx)
HR (1) HRP20030061A2 (xx)
HU (1) HUP0302982A3 (xx)
IL (1) IL153226A0 (xx)
IN (1) IN2002MU01649A (xx)
IS (1) IS6626A (xx)
MA (1) MA26931A1 (xx)
MX (1) MX233602B (xx)
MY (1) MY117831A (xx)
NO (1) NO324220B1 (xx)
NZ (1) NZ523226A (xx)
OA (1) OA12337A (xx)
PA (1) PA8523501A1 (xx)
PE (1) PE20020277A1 (xx)
PH (1) PH12001001922B1 (xx)
PL (1) PL365133A1 (xx)
PT (1) PT1305314E (xx)
SK (1) SK572003A3 (xx)
SV (1) SV2001000570A (xx)
TN (1) TNSN01112A1 (xx)
TW (1) TWI285643B (xx)
UA (1) UA72631C2 (xx)
UY (1) UY26854A1 (xx)
WO (1) WO2002010171A1 (xx)
YU (1) YU4703A (xx)
ZA (1) ZA200301457B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
JP4015176B2 (ja) 2003-04-29 2007-11-28 ファイザー・インク 高血圧症の治療に有用な５，７−ジアミノピラゾロ４，３−ジピリミジン類
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
US7569572B2 (en) 2004-04-07 2009-08-04 Pfizer Inc Pyrazolo[4,3-D]pyrimidines
BRPI0609225A2 (pt) 2005-05-12 2010-03-09 Pfizer formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200000969A1 (ru) * 1998-04-20 2001-06-25 Пфайзер Инк. ИНГИБИТОРЫ цГМБ ФДЭ5 НА ОСНОВЕ ПИРАЗОЛПИРИМИДИНОНА ДЛЯ ЛЕЧЕНИЯ ПОЛОВЫХ ДИСФУНКЦИЙ
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
DE60108398T2 (de) 2005-12-22
AU7269001A (en) 2002-02-13
CA2417264A1 (en) 2002-02-07
PH12001001922B1 (en) 2006-11-21
DOP2001000217A (es) 2002-10-30
ATE286901T1 (de) 2005-01-15
EA200300079A1 (ru) 2003-06-26
SV2001000570A (es) 2002-09-03
AR032628A1 (es) 2003-11-19
TNSN01112A1 (fr) 2005-11-10
HK1055954A1 (en) 2004-01-30
OA12337A (en) 2006-05-15
ZA200301457B (en) 2004-04-28
DE60108398D1 (de) 2005-02-17
EA004681B1 (ru) 2004-06-24
PL365133A1 (en) 2004-12-27
EP1305314A1 (en) 2003-05-02
KR20030016430A (ko) 2003-02-26
PA8523501A1 (es) 2002-10-24
IL153226A0 (en) 2003-07-06
CN1444585A (zh) 2003-09-24
DZ3364A1 (fr) 2002-02-07
WO2002010171A1 (en) 2002-02-07
MA26931A1 (fr) 2004-12-20
MY117831A (en) 2004-08-30
HRP20030061A2 (en) 2003-04-30
BG107266A (bg) 2003-07-31
IN2002MU01649A (xx) 2004-12-11
CN1207297C (zh) 2005-06-22
UY26854A1 (es) 2002-02-28
AU2001272690B2 (en) 2005-12-08
UA72631C2 (uk) 2005-03-15
TWI285643B (en) 2007-08-21
CA2417264C (en) 2007-06-12
EP1305314B1 (en) 2005-01-12
KR100457937B1 (ko) 2004-11-20
AP1400A (en) 2005-04-28
BR0112734A (pt) 2004-08-10
MXPA03000856A (es) 2003-06-06
PT1305314E (pt) 2005-04-29
AP2001002234A0 (en) 2001-09-30
ES2231521T3 (es) 2005-05-16
JP2004505087A (ja) 2004-02-19
HUP0302982A2 (hu) 2003-12-29
SK572003A3 (en) 2004-05-04
MX233602B (es) 2006-01-10
IS6626A (is) 2002-11-18
NO20030416L (no) 2003-02-05
NO20030416D0 (no) 2003-01-27
PE20020277A1 (es) 2002-05-11
YU4703A (sh) 2006-01-16
NZ523226A (en) 2003-07-25
ECSP034454A (es) 2003-03-10
GEP20053494B (en) 2005-04-25
EE200300045A (et) 2004-12-15
CZ2003126A3 (cs) 2004-02-18
HUP0302982A3 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
NO20071888L (no) Fremgangsmate for a syntetisere 4-aminosubstituerte forbindelser
NO20026197L (no) Fremgangsmåte for fremstilling av en blanding
NO20033905L (no) Fremgangsmåte for fremstilling av et voksholdig raffinat
FI20000564A0 (fi) Menetelmä nanolaminaattien valmistamiseksi
FI20002148A0 (fi) Menetelmä tuotteiden tateenottamiseksi
IL149292A0 (en) Method for graphically defining a formula
NO20030875L (no) Fremgangsmåte for fremstilling av en fast herbicid formulering
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
EE05146B1 (et) Meetod pulbriliste kompositsioonide valmistamiseks
IL209827A0 (en) A process for preparing pyrazole derivatives
NO20030163D0 (no) Fremgangsmåte for fremstilling av olefiner
NO20024145L (no) Regulerbar pakning for en produksjonsbrönn
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
HUP0100921A3 (en) Process for producing organic sylile alkyl polysulphanes
NO20013466L (no) Fremgangsmate for a produsere en metan-rik voske
HU0104405D0 (en) Process for preparing imidachlopid
FI991488A (fi) Menetelmä melatoniinipitoisen maidon tuottamiseksi
HUP0302765A3 (en) A process for the preparation of taxan derivatives
FI113053B (fi) Menetelmä polyaniliinin valmistamiseksi
NO324220B1 (no) Fremgangsmate for fremstilling av en polymorf
HK1048112B (zh) 3-乙烯基-頭孢化合物的製備方法
HUP0302277A3 (en) Process for preparing a substituted imidazopyridine compound
NO20014077D0 (no) Fremgangsmate for a krystallisere N-(4-trifluormetylfenyl)-5- metyl-isoksazol-4-karboksamid
HK1052350A1 (zh) 一種合成嗎啉基苯類化合物的新方法
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks